Could a common steroid prevent brain damage after carbon monoxide poisoning?
NCT ID NCT06574048
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early study tests whether adding the steroid dexamethasone to standard hyperbaric oxygen therapy helps prevent long-term brain problems after carbon monoxide poisoning. Twenty adults who receive hyperbaric oxygen will be randomly given either dexamethasone or a placebo. Researchers will track their thinking, memory, and emotions over time to see if the steroid improves recovery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Dexamethasone
What this could lead to
If it works, this could point toward a simple, low-cost way to reduce long-term brain damage after carbon monoxide poisoning.
What could go wrong
This is a very small, early pilot study with only 20 people. It may not show a clear benefit, and steroids carry risks like infection or blood sugar changes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARBON MONOXIDE POISONING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Nebraska Medicine, Hyperbaric Medicine Program, Clarkson Tower
Omaha, Nebraska, 68105, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••